Randox Laboratories Ltd. recalls RX Series Copper (Cu) Assay Ref. Number CU2340
- Recall date
- November 29, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0992-2024
- FDA classification
- Class II
- Brand / firm
- Randox Laboratories Ltd.
- Sold / distributed
- US Nationwide distribution in the states of SC and OK.
Why it was recalled
Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
RX Series Copper (Cu) Assay Ref. Number CU2340
Get recall alerts
Free email alert whenever Randox Laboratories Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Randox Laboratories Ltd.